Table 3—

Predictors of A1C after acute-phase and during maintenance-phase bupropion treatment of MDD

Predictor*After acute phase
During maintenance phase
βB (95% CI)PβB (95% CI)P
Change in BDI0.160.04 (0.00 to 0.08)0.0460.340.08 (0.03 to 0.12)0.001
Change in BMI0.190.30 (0.07 to 0.53)0.0130.120.12 (−0.05 to 0.3-)0.160
Change in SDSCA diet0.090.20 (−0.15 to 0.55)0.2500.020.04 (−0.33 to 0.40)0.835
Change in SDSCA exercise−0.03−0.03 (−0.18 to 0.11)0.6570.030.03 (−0.17 to 0.23)0.761
Change in SDSCA glucose testing0.050.05 (−0.11 to 0.22)0.5110.040.04 (−0.16 to 0.24)0.668
Change in diabetes management−0.01−0.02 (−0.67 to 0.62)0.945−0.06−0.20 (−0.77 to 0.36)0.480
Baseline A1C level0.820.71 (0.57 to 0.86)0.0000.870.68 (0.53 to 0.84)0.000
  • *

    * All change scores were calculated by subtracting baseline values from end point values as described under Research Design and Methods.